Imbalance production between interleukin-1β (IL-1β) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma

被引:54
|
作者
Mao, XQ
Kawai, M
Yamashita, T
Enomoto, T
Dake, Y
Sasaki, S
Kataoka, Y
Fukuzumi, T
Endo, K
Sano, H
Aoki, T
Kurimoto, F
Adra, CN
Shirakawa, T [1 ]
Hopkin, JM
机构
[1] Univ Coll Swansea, Expt Med Unit, Swansea, W Glam, Wales
[2] Kyoto Prevent Med Ctr, Kyoto, Japan
[3] Japanese Red Cross Soc, Dept Otolaryngol, Wakayama Med Ctr, Wakayama, Japan
[4] Sasaki Clin, Takatsuki, Osaka, Japan
[5] Habikino Hosp Osaka Prefecture, Dept Dermatol, Habikino, Japan
[6] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[7] Kyoto Univ, Grad Sch Publ Hlth, Dept Hlth Promot & Human Behav, Kyoto, Japan
关键词
D O I
10.1006/bbrc.2000.3516
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genes of the IL-I family encode three different peptides, IL-1 alpha, IL-1 beta, and IL-1Ra, respectively. IL-1 operates through IL-1RI, and is involved in airway inflammation in asthmatic subjects, whereas IL-1Ra appears to be a specific competitive inhibitor of IL-I. All genes are on chromosome 2q12-21 where genomewide searches have identified linkage for asthma. To test whether variants of IL-1 relate to asthma, we conducted a genetic association study in a Japanese population. We show that the A2 allele of IL1RN (encoding IL-1Ra) associates with nonatopic asthma [OR = 5.71, 95% CI: 1.63-19.8, Pc = 0.007]. Both atopic and nonatopic asthmatics with the A2 allele had significantly lower serum IL-1Ra levels in both types of asthmatics. Peripheral blood cells from asthmatics with A2 alleles, however, produced as much IL-1 as did those with Al homozygotes. Since Th1 and Th2 cytokines differentially regulate the ratio between IL-1 beta and IL-1Ra, these findings suggest that dysregulation of IL-1 beta/IL-1Ra, probably due to interaction between epithelium and immune-competent cells in the airway, is important in asthma inflammation. (C) 2000 Academic Press.
引用
收藏
页码:607 / 612
页数:6
相关论文
共 50 条
  • [41] Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra
    Muzio, M
    Polentarutti, N
    Facchetti, F
    Peri, G
    Doni, A
    Sironi, M
    Transidico, P
    Salmona, M
    Introna, M
    Mantovani, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (03) : 781 - 788
  • [42] Interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-lra) in patients with uveitis.
    Zhao, T
    Ahmed, M
    El-Shabrawi, Y
    Christen, W
    Baltatzis, S
    Foster, CS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U209 - U209
  • [43] THE SYNTHESIS OF IL-1 RECEPTOR ANTAGONIST (IL-1RA) BY SYNOVIAL FIBROBLASTS IS MARKEDLY INCREASED BY THE CYTOKINES TNF-ALPHA AND IL-1
    MARTELPELLETIER, J
    MCCOLLUM, R
    PELLETIER, JP
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1175 (03) : 302 - 305
  • [44] INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) PRODUCTION IN IGG MEDIATED HEMOLYSIS
    DAVENPORT, RD
    BURDICK, M
    STRIETER, RM
    KUNKEL, SL
    TRANSFUSION, 1992, 32 (08) : S45 - S45
  • [45] Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis
    Volarevic, Vladislav
    Al-Qahtani, Ahmed
    Arsenijevic, Nebojsa
    Pajovic, Sladjana
    Lukic, Miodrag L.
    AUTOIMMUNITY, 2010, 43 (04) : 255 - 263
  • [46] INTERLEUKIN-1(IL-1) PRODUCTION AND LEISHMANIASIS
    CRAWFORD, GD
    DINARELLO, CA
    WYLER, DJ
    WOLFF, SM
    CLINICAL RESEARCH, 1983, 31 (02): : A360 - A360
  • [47] THE EFFECT OF ANTIRHEUMATIC DRUGS ON INTERLEUKIN-1 (IL-1) ACTIVITY AND IL-1 AND IL-1 INHIBITOR PRODUCTION BY HUMAN MONOCYTES
    CHANG, DM
    BAPTISTE, P
    SCHUR, PH
    JOURNAL OF RHEUMATOLOGY, 1990, 17 (09) : 1148 - 1157
  • [48] A truncated form of the soluble IL-1 receptor type I which binds IL-1ra but not IL-1 alpha or IL-1 beta.
    Caffes, P
    Anderson, LJ
    Vigers, GPA
    Brandhuber, BJ
    PROTEIN ENGINEERING, 1997, 10 : 81 - 81
  • [49] EARLY INDUCTION OF IL-1 RECEPTOR ANTAGONIST (IL-1RA) IN INFANTS AND CHILDREN UNDERGOING SURGERY
    ONUALLAIN, EM
    PURI, P
    REEN, DJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1993, 93 (02): : 218 - 222
  • [50] The effects of interleukin-1 beta (IL-1 beta) on human thyrocyte functions are counteracted by the IL-1 receptor antagonist
    Rasmussen, AK
    Diamant, M
    BlichertToft, M
    Bendtzen, K
    FeldtRasmussen, U
    ENDOCRINOLOGY, 1997, 138 (05) : 2043 - 2048